sb 203580 has been researched along with At-V1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brook, AJ; Davis, T; Kipling, D; Tivey, HS | 1 |
1 other study(ies) available for sb 203580 and At-V1
Article | Year |
---|---|
Nijmegen breakage syndrome fibroblasts expressing the C-terminal truncated NBN(p70) protein undergo p38/MK2-dependent premature senescence.
Topics: Cell Cycle Proteins; Cell Proliferation; Cells, Cultured; Cellular Senescence; Enzyme Inhibitors; Fibroblasts; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Nijmegen Breakage Syndrome; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Phenotype; Protein Serine-Threonine Kinases; Pyridines; Signal Transduction; Telomere | 2015 |